环氧化酶-2在人肾透明细胞癌中的表达及其与肿瘤临床分期的相关性

Expression of cyclooxygenase-2 in human renal clear cell carcinoma and its correlation with clinical tumor stage

  • 摘要: 目的 研究环氧化酶-2(COX-2)在人肾透明细胞癌组织中的表达,分析其表达水平与肿瘤分期的关系。方法 应用免疫组织化学技术检测48例人肾透明细胞癌组织和28例正常人肾组织标本中COX-2的表达水平;48例肾透明细胞癌患者,其中T1a期8例、T1b期18例、T2期10例、T3-T4期12例。结果 48例人肾透明细胞癌组织中COX-2表达阳性率为75%,定位于胞浆,且其表达强度随肿瘤临床分期的升高而增加(r=0.731,P<0.01),而在正常人肾组织中均为阴性。结论 COX-2在人肾透明细胞癌中表达升高,且其表达强度与临床分期密切相关。提示COX-2可能作为肾癌发展及恶化的预测因素,为将来应用COX-2抑制剂治疗肾癌提供了理论依据。

     

    Abstract: Objective To study the expression of cyclooxygenase-2(COX-2) in renal clear cell carcinoma tissues and its relation with the clinical tumor stage.Methods Expression of COX-2 in renal tissue samples from 48 cases of cell carcinoma and in normal renal tissue samples from 28 healthy controls was detected by immunohistochemistry.Of the 48 cases of renal clear cell carcinoma,8,18,10 and 12 were staged as T1a,T1b,T2 and T3-T4,respectively.Results The positive expression rate of COX-2 in renal clear cell carcinoma tissue samples from 48 cases of cell carcinoma was 75%,which was located in cytoplasm and increased with the clinical tumor stage(r=0.731,P<0.01).COX-2 was negatively expressed in normal renal tissue samples from 28 healthy controls.Conclusion The expression of COX-2 is increased in renal cell carcinoma and is closely related with the clinical tumor stage,indicating that COX-2 can be used as a predictive factor for the development and progression of renal cell carcinoma,thus providing a theoretical basis for its application in treatment of renal carcinoma.

     

/

返回文章
返回